Cholesteryl Hemisuccinate Bulk Price Global Manufacturer 2026
- Industrial Pricing: Bulk procurement offers significant cost reductions compared to milligram-scale research catalog pricing.
- Quality Assurance: High industrial purity standards ensure stability for liposome and drug delivery systems.
- Supply Chain: Reliable global manufacturer partnerships mitigate logistics risks for 2026 production cycles.
The pharmaceutical and biotechnology sectors are increasingly reliant on high-quality lipid intermediates for advanced drug delivery systems. As we approach 2026, the demand for stable, scalable sources of cholesterol derivatives is accelerating. Among these, Cholesteryl Hemisuccinate (CAS: 1510-21-0) stands out as a critical component for stabilizing unilamellar vesicles and liposomes. For procurement managers and process chemists, understanding the disparity between research-grade catalog pricing and industrial bulk rates is essential for budget optimization.
Market analysis indicates that small-scale research vendors often price this compound at exorbitant rates, sometimes exceeding $70,000 per kilogram when extrapolated from gram-scale units. In contrast, partnering with a dedicated global manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. provides access to true bulk pricing structures designed for commercial production. This article analyzes the technical specifications, synthesis considerations, and pricing trends necessary for securing supply in the coming fiscal year.
Market Pricing Trends for Metric Ton Quantities
The pricing landscape for lipid intermediates is bifurcated. On one side exist research suppliers catering to laboratory-scale experiments, where convenience commands a premium. On the other side are industrial manufacturers focused on metric ton quantities. Data suggests that while 2.5g units may cost upwards of $177 USD, bulk contracts negotiate prices based on production volume and purity requirements.
For 2026, buyers should anticipate fluctuations based on raw material availability, specifically cholesterol and succinic anhydride feedstocks. However, established manufacturers maintain price stability through long-term supplier agreements. When evaluating a bulk price proposal, it is critical to distinguish between the free acid form and salt forms, such as the Tris salt, as the molecular weight and stoichiometry differ significantly. The free acid (MW 486.7) is typically preferred for esterification processes where precise molar calculations are required.
Procurement strategies should focus on total cost of ownership, which includes logistics, customs, and quality verification. A lower unit price from an unverified source often leads to higher costs downstream due to failed batch testing or inconsistent emulsification performance in final formulations.
Evaluating Global Manufacturer Supply Chain Stability
Supply chain resilience is paramount for continuous manufacturing operations. A reliable partner must demonstrate robust capacity planning and inventory management. NINGBO INNO PHARMCHEM CO.,LTD. emphasizes vertical integration in their manufacturing process, ensuring that critical lipid intermediates remain available even during global logistical disruptions.
Key indicators of supply chain stability include:
- Production Capacity: Ability to scale from kilograms to tons without altering the synthesis route or compromising quality.
- Documentation: Provision of a comprehensive COA (Certificate of Analysis) with every batch, detailing impurity profiles and residual solvents.
- Storage and Handling: Adherence to strict storage protocols, typically requiring temperatures around -20°C for long-term stability to prevent hydrolysis.
Industrial clients should request audit reports or quality management certifications to verify that the manufacturer operates under stringent controls. This due diligence prevents interruptions in the production of liposomal drugs, antibiotics, or oligonucleotide delivery systems where this compound acts as a crucial emulsifying agent.
Technical Specifications and Synthesis Overview
From a process chemistry perspective, the quality of Cholesterol Hydrogen Succinate is defined by its esterification efficiency and residual acid content. The compound is formally known as (3beta)-cholest-5-en-3-ol 3-(hydrogen butanedioate). It acts as an ionizable anionic detergent, making it invaluable for solubilizing membrane proteins and stabilizing lipid bilayers.
When sourcing high-purity Cholesteryl Hemisuccinate, buyers should verify the molecular formula C31H50O4 and ensure the absence of di-esterified byproducts. The synthesis typically involves the reaction of cholesterol with succinic anhydride in the presence of a base catalyst. Optimizing this synthesis route is crucial for maximizing yield and minimizing purification costs.
Maintaining industrial purity above 95% is standard for most applications, though specific therapeutic uses may require higher thresholds. Impurities can affect the critical micelle concentration (CMC) and the physical stability of the resulting liposomes. Therefore, analytical verification via HPLC or NMR is recommended upon receipt of bulk shipments.
Physical and Chemical Properties
The following table outlines the critical technical data required for quality control and regulatory filing:
| Parameter | Specification |
|---|---|
| Product Name | Cholesteryl Hemisuccinate (Free Acid) |
| CAS Number | 1510-21-0 |
| Molecular Formula | C31H50O4 |
| Molecular Weight | 486.7 g/mol |
| Purity | >95% (Industrial Grade) |
| Appearance | Crystalline Solid |
| Solubility | Chloroform (10 mg/mL), Ethanol, DMSO |
| Storage Conditions | -20°C (Long-term), Protected from Light |
Cost Analysis vs Laboratory Grade Suppliers
The economic argument for shifting from laboratory-grade suppliers to industrial manufacturers is compelling. Research catalogs often package this material in milligram quantities with significant markup to cover handling and marketing costs. For example, a 2.5g unit priced at $177 USD translates to a prohibitive cost structure for commercial scaling.
Industrial procurement eliminates these markups. By engaging directly with a manufacturer, companies secure volumes that align with production schedules rather than experimental needs. This shift not only reduces the cost per gram but also ensures consistency across batches. Consistency is vital when the compound is used to stabilize erythrocyte ghosts or formulate anticancer agents where batch-to-batch variability can alter clinical outcomes.
Furthermore, industrial suppliers offer customization options regarding particle size and packaging that research vendors do not. Whether the requirement is for bulk drums or specialized containment for moisture-sensitive environments, a dedicated manufacturing partner provides the flexibility needed for large-scale operations.
Conclusion
As the biopharmaceutical industry advances toward 2026, the strategic sourcing of lipid intermediates becomes a competitive advantage. Cholesteryl Hemisuccinate remains a cornerstone molecule for liposomal technology and drug delivery innovation. By prioritizing industrial purity, verifying the synthesis route, and securing favorable bulk price agreements, organizations can safeguard their production pipelines.
For reliable supply and technical support, partnering with an established entity like NINGBO INNO PHARMCHEM CO.,LTD. ensures access to high-quality materials backed by rigorous quality control. Procurement teams are encouraged to request samples and review current COA documentation to validate specifications before committing to long-term contracts.